Apollo Hospitals beats the Street, declares dividend of ₹10 as net profit surges 33%

Apollo Hospitals Enterprise Ltd on Wednesday (May 20) reported a consolidated net profit of ₹547.2 crore for the fourth quarter, up 33% year-on-year compared with ₹412 crore in the corresponding period last year.

The company’s Q4 net profit also exceeded CNBC-TV18 poll estimates of ₹452.5 crore. Revenue rose 18.1% year-on-year to ₹6,606 crore from ₹5,592 crore, and was higher than CNBC-TV18 poll estimates of ₹6,447 crore.

EBITDA increased 31.3% year-on-year to ₹1,011 crore from ₹770 crore, surpassing CNBC-TV18 poll estimates of ₹936 crore. EBITDA margin stood at 15.3%, compared with 13.8% in the same quarter last year and against poll estimates of 14.5%.

Also Read: Apollo Hospitals Q3 Results: Profit up 35%, revenue beat estimates; dividend declared

The board recommended a final dividend of ₹10 per equity share, equivalent to 200% of the face value of ₹5 per share, for FY2025-26, subject to shareholder approval at the ensuing Annual General Meeting.

The board has fixed August 14, 2026, as the record date for determining eligible shareholders for the final dividend and for the AGM. If approved at the AGM, the dividend will be paid on or before September 10, 2026.

The board, based on the recommendation of the Nomination and Remuneration Committee, also approved the re-appointment of Dr Prathap C Reddy as Executive Chairman for a further period of two years with effect from June 25, 2026, subject to shareholder approval at the AGM.

Also Read: Apollo Hospitals shares may rally 33% from current levels; Citi cites attractive valuations

Shares of Apollo Hospitals Enterprise Ltd ended at ₹8,066.25, up by ₹40.25, or 0.50%, on the BSE.